{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T10:50:27Z","timestamp":1776423027056,"version":"3.51.2"},"reference-count":59,"publisher":"The Endocrine Society","issue":"5","license":[{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>Multiple endocrine neoplasia type 1 (MEN1) is a hereditary tumor predisposing syndrome, characterized by typical neuroendocrine tumors in parathyroid, pituitary, and endocrine pancreas tissues (\u201c3P\u201d). MEN1 is also associated with non-neuroendocrine cancers, which are less studied.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To assess the prevalence of certain non-neuroendocrine cancers associated with MEN1 in Finnish patients and compare the findings with a local control population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Retrospective registry-based cohort study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>113 MEN1 patients (51 males) treated at Oulu University Hospital between 1982 and 2023, with an average follow-up of 56 patient-years, were compared to a local control population (n = 1\u2005045\u2005520 males, average follow-up of 73 patient-years). Data were analyzed using descriptive statistics, survival curves, and Cox regression models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Seven women with MEN1 (11.5%) had breast cancer (BC), 7 (6.2%) with papillary thyroid carcinoma (PTC), and 5 (4.4%) with renal cancers (RC). The mean age at BC diagnosis was 49 years compared to 60 in the general Finnish population. The hazard ratio (HR) for BC in female MEN1 patients was 3.79 (95% CI: 1.66-8.60) compared to controls. Pathogenic variants in established BC risk genes were not present in our MEN1 patients. The HR for PTC and RC were 9.37 (3.59-24.41) and 7.80 (2.74-22.25), respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study demonstrates a significantly increased prevalence of BC, PTC, and RC in MEN1 patients compared to the Finnish general population. The findings support earlier BC screening in women with MEN1 and highlight the need for further research into non-neuroendocrine cancer risks in these patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/jendso\/bvag080","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T11:32:32Z","timestamp":1775561552000},"source":"Crossref","is-referenced-by-count":1,"title":["Associations of selected atypical non-neuroendocrine cancers with multiple endocrine neoplasia type 1"],"prefix":"10.1210","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1164-5640","authenticated-orcid":false,"given":"Iina","family":"Yliaska","sequence":"first","affiliation":[{"name":"Medical Research Center Oulu, Oulu University Hospital, Research Unit of Biomedicine and Internal Medicine, University of Oulu , Oulu FIN-90029 ,","place":["Finland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joona","family":"Tapio","sequence":"additional","affiliation":[{"name":"Research Unit of Extracellular Matrix and Hypoxia, Biocenter Oulu and Faculty of Biochemistry and Molecular Medicine, University of Oulu , Oulu FIN-90014 ,","place":["Finland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timo A","family":"Kumpula","sequence":"additional","affiliation":[{"name":"Laboratory of Cancer Genetics and Tumor Biology, Translational Medicine Research Unit, Medical Research Center Oulu and Biocenter Oulu, University of Oulu , Oulu FIN-90014 ,","place":["Finland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vesa-Matti","family":"Pohjanen","sequence":"additional","affiliation":[{"name":"Cancer and Translational Medicine Research Unit, Medical Research Center Oulu, University of Oulu and Oulu University Hospital , Oulu FIN-90029 ,","place":["Finland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tapani","family":"Ebeling","sequence":"additional","affiliation":[{"name":"Medical Research Center Oulu, Oulu University Hospital, Research Unit of Biomedicine and Internal Medicine, University of Oulu , Oulu FIN-90029 ,","place":["Finland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olavi","family":"Ukkola","sequence":"additional","affiliation":[{"name":"Medical Research Center Oulu, Oulu University Hospital, Research Unit of Biomedicine and Internal Medicine, University of Oulu , Oulu FIN-90029 ,","place":["Finland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Outi","family":"Kuismin","sequence":"additional","affiliation":[{"name":"Department of Clinical Genetics, Research Unit of Clinical Medicine, Medical Research Center Oulu, Oulu University Hospital and University of Oulu , Oulu FIN-90029 ,","place":["Finland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minna","family":"Koivikko","sequence":"additional","affiliation":[{"name":"Medical Research Center Oulu, Oulu University Hospital, Research Unit of Biomedicine and Internal Medicine, University of Oulu , Oulu FIN-90029 ,","place":["Finland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katri","family":"Pylk\u00e4s","sequence":"additional","affiliation":[{"name":"Laboratory of Cancer Genetics and Tumor Biology, Translational Medicine Research Unit, Medical Research Center Oulu and Biocenter Oulu, University of Oulu , Oulu FIN-90014 ,","place":["Finland"]},{"name":"Northern Finland Laboratory Centre Nordlab , Oulu FIN-90220 ,","place":["Finland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pasi I","family":"Salmela","sequence":"additional","affiliation":[{"name":"Medical Research Center Oulu, Oulu University Hospital, Research Unit of Biomedicine and Internal Medicine, University of Oulu , Oulu FIN-90029 ,","place":["Finland"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2026,4,8]]},"reference":[{"issue":"5311","key":"2026041705515027900_bvag080-B1","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1126\/science.276.5311.404","article-title":"Positional cloning of the gene for multiple endocrine neoplasia type 1","volume":"276","author":"Chandrasekharappa","year":"1997","journal-title":"Science"},{"issue":"2","key":"2026041705515027900_bvag080-B2","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1210\/endrev\/bnaa031","article-title":"Multiple endocrine neoplasia type 1: latest insights","volume":"42","author":"Brandi","year":"2021","journal-title":"End Rev"},{"issue":"7","key":"2026041705515027900_bvag080-B3","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1080\/17501911.2025.2485019","article-title":"Menin: from molecular insights to clinical impact","volume":"17","author":"Brown","year":"2025","journal-title":"Epigenomics"},{"issue":"7386","key":"2026041705515027900_bvag080-B4","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nature10806","article-title":"The same pocket in menin binds both MLL and JUND but has opposite effects on transcription","volume":"K482","author":"Huang","year":"2012","journal-title":"Nature"},{"issue":"4","key":"2026041705515027900_bvag080-B5","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41574-021-00468-3","article-title":"Clinical aspects of multiple endocrine neoplasia type 1","volume":"17","author":"Al-Salameh","year":"2021","journal-title":"Nature Rev Endocrinol"},{"issue":"4","key":"2026041705515027900_bvag080-B6","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/cen.14727","article-title":"Update on the clinical management of multiple endocrine neoplasia type 1","volume":"97","author":"Pieterman","year":"2022","journal-title":"Clin Endocrinol"},{"key":"2026041705515027900_bvag080-B7","doi-asserted-by":"crossref","first-page":"1029041","DOI":"10.3389\/fendo.2022.1029041","article-title":"Beyond the \u201c3 Ps\u201d: a critical appraisal of the non-endocrine manifestations of multiple endocrine neoplasia type 1","volume":"13","author":"Waguespack","year":"2022","journal-title":"Front Endocrinol"},{"issue":"6","key":"2026041705515027900_bvag080-B8","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1056\/NEJMc1406028","article-title":"Breast-cancer predisposition in multiple endocrine neoplasia type 1","volume":"371","author":"Dreijerink","year":"2014","journal-title":"N Engl J Med"},{"issue":"6","key":"2026041705515027900_bvag080-B9","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1210\/jc.2016-3690","article-title":"MEN1-dependent breast cancer: indications for early screening? Results from the Dutch MEN1 study group","volume":"102","author":"van Leeuwaarde","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2026041705515027900_bvag080-B10","doi-asserted-by":"crossref","first-page":"513","DOI":"10.4183\/aeb.2019.513","article-title":"Adrenal incidentaloma, breast cancer and unrecognized multiple endocrine neoplasia type 1","volume":"15","author":"Kim","year":"2019","journal-title":"Acta Endocrinol (Buc)"},{"issue":"8","key":"2026041705515027900_bvag080-B11","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1007\/s40618-023-02288-w","article-title":"The risk of concurrent malignancies in patients with multiple endocrine type 1: insights into clinical characteristics of those with multiple endocrine neoplasia type 1","volume":"47","author":"Zhao","year":"2024","journal-title":"J Endocrinol Invest"},{"issue":"8","key":"2026041705515027900_bvag080-B12","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1507\/endocrj.EJ14-0021","article-title":"Sarcomatoid carcinoma of the kidney in a MEN1 patient: case report and genetic profile","volume":"61","author":"Cavalli","year":"2014","journal-title":"Endocr J"},{"issue":"2","key":"2026041705515027900_bvag080-B13","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1046\/j.1365-2796.1999.00429.x","article-title":"Prevalence of the metabolic syndrome in drug-treated hypertensive patients and control subjects","volume":"245","author":"Rantala","year":"1999","journal-title":"J Intern Med"},{"key":"2026041705515027900_bvag080-B14","doi-asserted-by":"crossref","unstructured":"Yliaska I. \u00a0Supplementary material for the manuscript: \u201cAssociations of selected atypical non-neuroendocrine cancers with multiple endocrine neoplasia type 1\u201d. Zenodo. Published online March 24, 2026.","DOI":"10.1210\/jendso\/bvag080"},{"issue":"3","key":"2026041705515027900_bvag080-B15","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s12020-022-03099-4","article-title":"Thymic neuroendocrine tumors in patients with multiple endocrine neoplasia type 1","volume":"77","author":"Yliaska","year":"2022","journal-title":"Endocrine"},{"issue":"7","key":"2026041705515027900_bvag080-B16","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1210\/jc.2003-031513","article-title":"Effect of multiple endocrine neoplasia type 1 (MEN1) gene mutations on premature mortality in familial MEN1 syndrome with founder mutations","volume":"89","author":"Ebeling","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2026041705515027900_bvag080-B17","doi-asserted-by":"crossref","first-page":"e176993","DOI":"10.1172\/jci.insight.176993","article-title":"Genotype\u2013phenotype correlations in multiple endocrine neoplasia type 1","volume":"10","author":"Worthy","year":"2025","journal-title":"JCI Insight"},{"issue":"1","key":"2026041705515027900_bvag080-B18","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3892\/ol.2014.2144","article-title":"Multiple endocrine neoplasia type 1 associated endocrine neoplasia type 1 associated with breast cancer: a case report and review of the literature","volume":"8","author":"Jeong","year":"2014","journal-title":"Oncology Lett"},{"key":"2026041705515027900_bvag080-B19","first-page":"468","article-title":"Multiple endocrine neoplasia type 1 and breast cancer: an association to consider","volume":"65","author":"Herranz-Antolin","year":"2018","journal-title":"Endocrinol Diabetes Nutr"},{"issue":"4","key":"2026041705515027900_bvag080-B20","doi-asserted-by":"crossref","first-page":"e00092","DOI":"10.1002\/edm2.92","article-title":"Co-occurrence of breast cancer and neuroendocrine tumours: new genetic insights beyond multiple endocrine neoplasia syndromes","volume":"2","author":"Larouche","year":"2019","journal-title":"Endocrinol Diabetes Metab"},{"issue":"12","key":"2026041705515027900_bvag080-B21","doi-asserted-by":"crossref","first-page":"e238784","DOI":"10.1136\/bcr-2020-238784","article-title":"Incidental finding of MEN1 syndrome during staging and follow-up of breast carcinoma","volume":"13","author":"Maria","year":"2020","journal-title":"BMJ Case Rep"},{"key":"2026041705515027900_bvag080-B22","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.ijscr.2020.11.073","article-title":"Axillary hibernoma in woman with lobular breast cancer and MEN1: a case report","volume":"77","author":"Deguidi","year":"2020","journal-title":"Int J Surg Case Rep"},{"key":"2026041705515027900_bvag080-B23","first-page":"1","article-title":"Breast cancer in multiple endocrine neoplasia type 1 (MEN1)","author":"Cheah","year":"2021","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"2026041705515027900_bvag080-B24","first-page":"e48313","article-title":"Coincidental occurrence of multiple endocrine neoplasia type 1 and breast cancer in a young Saudi girl: a case study and genetic analysis","volume":"L15","author":"Alhefdhi","year":"2023","journal-title":"Cureus"},{"issue":"1","key":"2026041705515027900_bvag080-B25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000505498","article-title":"Gender differences in multiple endocrine neoplasia type 1: implication for screening","volume":"36","author":"Manoharan","year":"2020","journal-title":"Visc Med"},{"key":"2026041705515027900_bvag080-B26","doi-asserted-by":"crossref","first-page":"1191040","DOI":"10.3389\/fendo.2023.1191040","article-title":"Cutaneous lesions and other non-endocrine manifestations of multiple endocrine neoplasia type 1 syndrome","volume":"14","author":"Pierotti","year":"2013","journal-title":"Front Endocrinol"},{"issue":"10","key":"2026041705515027900_bvag080-B27","doi-asserted-by":"crossref","first-page":"T135","DOI":"10.1530\/ERC-17-0281","article-title":"Twenty years of menin: emerging opportunities for restoration of transcriptional regulation in MEN1","volume":"24","author":"Dreijerink","year":"2017","journal-title":"Endocr Relat Cancer"},{"issue":"9","key":"2026041705515027900_bvag080-B28","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.3390\/genes15091231","article-title":"Menin in cancer","volume":"15","author":"Majer","year":"2024","journal-title":"Genes (Basel)"},{"issue":"10","key":"2026041705515027900_bvag080-B29","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1016\/j.celrep.2017.02.025","article-title":"Enhancer-mediated oncogenic function of the menin tumor suppression in breast cancer","volume":"18","author":"Dreijerink","year":"2017","journal-title":"Cell Rep"},{"issue":"2","key":"2026041705515027900_bvag080-B30","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3390\/endocrines1020007","article-title":"Involvement of the MEN1 gene in hormone-related cancers: clues from molecular studies, mouse models and patient investigations","volume":"1","author":"Abou Ziki","year":"2020","journal-title":"Endocrines"},{"issue":"1","key":"2026041705515027900_bvag080-B31","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13072-022-00461-8","article-title":"Multi-omics analyses of MEN 1 missense mutations identify disruptions of menin-MLL and menin-JunD interactions as critical requirements for molecular pathogenicity","volume":"15","author":"Dreijerink","year":"2022","journal-title":"Epigenetics Chromatin"},{"issue":"9","key":"2026041705515027900_bvag080-B32","doi-asserted-by":"crossref","first-page":"4929","DOI":"10.1158\/0008-5472.CAN-05-4461","article-title":"Menin links estrogen receptor activation to histone H3K4 trimethylation","volume":"66","author":"Dreijerink","year":"2006","journal-title":"Cancer Res"},{"issue":"2","key":"2026041705515027900_bvag080-B33","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s10549-009-0581-0","article-title":"Menin, a product of the MEN1 gene, binds to estrogen receptor to enhance its activity in breast cancer cells: possibility of a novel predictive factor for tamoxifen resistance","volume":"122","author":"Imachi","year":"2010","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"2026041705515027900_bvag080-B34","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/path.4146","article-title":"High incidence of mammary intraepithelial neoplasia development in Men1-disrupted murine mammary glands","volume":"229","author":"Seigne","year":"2013","journal-title":"J Pathol"},{"issue":"3","key":"2026041705515027900_bvag080-B35","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s10549-021-06339-9","article-title":"Reduced menin expression leads to decreased ER\u03b1 expression and is correlated with the occurrence of human luminal B-like and ER-negative breast cancer subtypes","volume":"190","author":"Teinturier","year":"2021","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"2026041705515027900_bvag080-B36","doi-asserted-by":"crossref","first-page":"e0288482","DOI":"10.1371\/journal.pone.0288482","article-title":"Evaluating the role of MEN1 gene expression and its clinical significance in breast cancer patients","volume":"18","author":"Massey","year":"2023","journal-title":"PLoS One"},{"issue":"9","key":"2026041705515027900_bvag080-B37","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1210\/me.2003-0154","article-title":"Heterozygous MEN1 mutant mice develop a range of endocrine tumors mimiching multiple endocrine neoplasia type 1","volume":"17","author":"Bertolino","year":"2003","journal-title":"Mol. Endocrinol"},{"issue":"3","key":"2026041705515027900_bvag080-B38","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/cen.12614","article-title":"Breast cancer risk in MEN1\u2014a cancer perspective","volume":"82","author":"Brennan","year":"2015","journal-title":"Clin Endocrinol"},{"key":"2026041705515027900_bvag080-B39","first-page":"49","article-title":"Breast cancer: pathogenesis and treatments","volume":"10","author":"Xiong","year":"2025","journal-title":"Sign Transd Targ Ther"},{"key":"2026041705515027900_bvag080-B40","doi-asserted-by":"crossref","first-page":"101118","DOI":"10.1016\/j.currproblcancer.2024.101118","article-title":"Menin signaling and therapeutic targeting in breast cancer","volume":"51","author":"Liu","year":"2024","journal-title":"Curr Probl Cancer"},{"issue":"8","key":"2026041705515027900_bvag080-B41","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.annonc.2025.04.012","article-title":"Breast cancer germline multigene panel testing in mainstream oncology based on clinical-public health utility: ESMO precision oncology working group recommendations","volume":"36","author":"Turnbull","year":"2025","journal-title":"An Oncol"},{"issue":"2","key":"2026041705515027900_bvag080-B42","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.cancergencyto.2007.08.009","article-title":"A carrier of both MEN1 and BRCA2 mutations: case report and review of the literature","volume":"179","author":"Ghataorhe","year":"2007","journal-title":"Cancer Genet Cytogenet"},{"issue":"1","key":"2026041705515027900_bvag080-B43","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.cancergencyto.2009.06.019","article-title":"Germline mutations in MEN1 and BRCA1 genes in a woman with familial multiple endocrine neoplasia type 1 and inherited breast-ovarian cancer syndromes: a case report","volume":"195","author":"Papi","year":"2009","journal-title":"Cancer Genet Cytogenet"},{"issue":"7605","key":"2026041705515027900_bvag080-B44","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature17676","article-title":"Landscape of somatic mutations in 560 breast cancer whole genome sequences","volume":"534","author":"Nik-Zainal","year":"2016","journal-title":"Nature"},{"issue":"5","key":"2026041705515027900_bvag080-B45","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1056\/NEJMoa1913948","article-title":"Breast Cancer risk Genes-association analysis in more than 113 000 women","volume":"384","author":"Breast Cancer Association Consortium","year":"2021","journal-title":"N Engl J Med"},{"issue":"5","key":"2026041705515027900_bvag080-B46","doi-asserted-by":"crossref","first-page":"448","DOI":"10.21873\/cgp.20463","article-title":"The clinical and genetic landscape of hereditary cancer: experience from a single clinical diagnostic laboratory","volume":"21","author":"Tsoulos","year":"2024","journal-title":"Cancer Genom Proteom"},{"issue":"4","key":"2026041705515027900_bvag080-B47","doi-asserted-by":"crossref","first-page":"bbae346","DOI":"10.1093\/bib\/bbae346","article-title":"Discovering predisposing genes for hereditary breast cancer using deep leaning","volume":"25","author":"Passi","year":"2024","journal-title":"Brief Bioinform"},{"issue":"11","key":"2026041705515027900_bvag080-B48","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1158\/2159-8290.CD-20-1647","article-title":"Genomic and transcriptomic analyses of breast cancer primaries and matched metastasis in Aurora","volume":"11","author":"Aftimos","year":"2021","journal-title":"Cancer Discov"},{"issue":"3","key":"2026041705515027900_bvag080-B49","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3349\/ymj.2008.49.3.503","article-title":"A case of multiple endocrine neoplasia type 1 combined with papillary thyroid carcinoma","volume":"49","author":"Kim","year":"2008","journal-title":"Yonse Med J"},{"issue":"9","key":"2026041705515027900_bvag080-B50","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1210\/jc.2012-1230","article-title":"Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)","volume":"97","author":"Thakker","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026041705515027900_bvag080-B51","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/BF03401410","article-title":"Multiple endocrine neoplasia type 1 associated with a new germline MEN1 mutation in a family with atypical tumor phenotype","volume":"15","author":"Perakakis","year":"2016","journal-title":"Hormones"},{"issue":"19","key":"2026041705515027900_bvag080-B52","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1056\/NEJMp1409841","article-title":"Korea's thyroid-cancer epidemic. Screening and overdiagnosis","volume":"371","author":"Ahn","year":"2014","journal-title":"N Engl J Med"},{"key":"2026041705515027900_bvag080-B53","first-page":"919","article-title":"Multiple endocrine neoplasia type 1: atypical presentation, clinical course, and genetic analysis of multiple tumors","volume":"12","author":"Vortmeyer","year":"1999","journal-title":"Mod Pathol"},{"issue":"4","key":"2026041705515027900_bvag080-B54","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s10434-001-0342-8","article-title":"Genetic analysis of a papillary thyroid carcinoma in a patient with MEN1","volume":"8","author":"Desai","year":"2001","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"2026041705515027900_bvag080-B55","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1210\/mend-5-12-1873","article-title":"Allelotype of human thyroid tumors. Loss of chromosome 11q13 sequences in follicular neoplasms","volume":"5","author":"Matsuo","year":"1991","journal-title":"Mol Endocrinol"},{"issue":"1","key":"2026041705515027900_bvag080-B56","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1530\/EJE-10-0950","article-title":"Gender-related differences in MEN1 lesions occurrence and diagnosis: a cohort study of 734 cases from group d\u2019etude des tumeurs endocrines","volume":"165","author":"Goudet","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"2026041705515027900_bvag080-B57","doi-asserted-by":"publisher","DOI":"10.1111\/cen.15209","article-title":"Breast cancer risk and management in the endocrine clinic: a comprehensive review","author":"Hawazie","year":"2025","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"2026041705515027900_bvag080-B58","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.eprac.2025.02.001","article-title":"American association of clinical endocrinology consensus statement on management of multiple endocrine neoplasia type 1","volume":"31","author":"Del Rivero","year":"2025","journal-title":"Endocr Pract"},{"issue":"8","key":"2026041705515027900_bvag080-B59","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S2213-8587(25)00119-6","article-title":". Multiple endocrine neoplasia type 1 (MEN1): recommendations and guidelines to best practice","volume":"13","author":"Brandi","year":"2025","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["Journal of the Endocrine Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jes\/advance-article-pdf\/doi\/10.1210\/jendso\/bvag080\/67989162\/bvag080.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jes\/article-pdf\/10\/5\/bvag080\/68103814\/bvag080.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jes\/article-pdf\/10\/5\/bvag080\/68103814\/bvag080.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T09:52:07Z","timestamp":1776419527000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jes\/article\/doi\/10.1210\/jendso\/bvag080\/8643913"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,7]]},"references-count":59,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,4,7]]}},"URL":"https:\/\/doi.org\/10.1210\/jendso\/bvag080","relation":{},"ISSN":["2472-1972"],"issn-type":[{"value":"2472-1972","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5]]},"published":{"date-parts":[[2026,4,7]]},"article-number":"bvag080"}}